Content area

|
|

Nye hormoner relateret til calcium- og fosfathomøostasen ved nyresygdom

Forfatter(e)
Maria Lerche Mace1, Klaus Ølgaard2 & Ewa Lewin1 1) Nefrologisk Afdeling, Herlev-Gentofte Hospital 2) Nefrologisk Afdeling, Rigshospitalet Ugeskr Læger 2018;180:V05170353
Reference: 
Ugeskr Læger 2018;180:V05170353
Sidetal: 
2-5
Novel hormones related to the calcium and phosphate homeostasis in kidney disease
Calcium and phosphate levels are regulated by a complex interplay between parathyroid hormone (PTH), calcitriol, fibroblast growth factor 23 (FGF23) and its co-receptor αKlotho. Kidney failure causes severe disturbances in the mineral and bone homeostasis resulting in phosphate retention, hypocalcaemia and high plasma levels of FGF23 and PTH, and the patients develop fragile bones and vascular calcifications. Today’s treatments aim to lower the levels of phosphate and PTH. Future studies need to clarify, if lowering the FGF23 level or supplementation with αKlotho will improve survival for patients with chronic kidney disease.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Kirsten Ilkjær | 22/10
1 Kommentar
af Camilla Bang | 21/10
3 kommentarer
af Anne Gersdorff Korsgaard | 20/10
1 Kommentar
af Karen Brink Linnet | 19/10
1 Kommentar
af Thor Andersen Knudsen | 19/10
2 kommentarer
af Ole Lindgård Dollerup | 18/10
1 Kommentar
af Kristine Rasmussen | 18/10
1 Kommentar